{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T04:28:59Z","timestamp":1786422539818,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Pediatr"],"DOI":"10.1007\/s00431-026-07221-w","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T06:23:35Z","timestamp":1783664615000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Respiratory evolution after antenatal betamethasone dose reduction in very preterm neonates: a post hoc analysis of the BETADOSE trial"],"prefix":"10.1007","volume":"185","author":[{"given":"Lauren","family":"Saade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Baud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Treluyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Yves","family":"Ancel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Aupiais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9lo\u00efse","family":"Torchin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"7221_CR1","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004454.pub4","author":"E McGoldrick","year":"2020","unstructured":"McGoldrick E, Stewart F, Parker R, Dalziel SR (2020) Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD004454.pub4. (pub4 PubMed PMID: 33368142; PubMed Central PMCID: PMC8094626.)","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"7221_CR2","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1542\/peds.50.4.515","volume":"50","author":"GC Liggins","year":"1972","unstructured":"Liggins GC, Howie RN (Oct1972) A controlled trial of antepartum glucocorticoid treatment for prevention of the respiratory distress syndrome in premature infants. Pediatrics 50(4):515\u2013525 (PubMed PMID: 4561295)","journal-title":"Pediatrics"},{"issue":"8","key":"7221_CR3","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1111\/1471-0528.17027","volume":"129","author":"S Stock","year":"2022","unstructured":"Stock S, Thomson A, Papworth S, the Royal College of Obstetricians and Gynaecologists, (2022) Antenatal corticosteroids to reduce neonatal morbidity and mortality. BJOG Int J Obstet Gynaecol. 129(8):e35-60. https:\/\/doi.org\/10.1111\/1471-0528.17027","journal-title":"BJOG Int J Obstet Gynaecol."},{"issue":"6","key":"7221_CR4","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2022.0483","volume":"176","author":"K Ninan","year":"2022","unstructured":"Ninan K, Liyanage SK, Murphy KE, Asztalos EV, McDonald SD (2022) Evaluation of long-term outcomes associated with preterm exposure to antenatal corticosteroids: a systematic review and meta-analysis. JAMA Pediatr. 176(6):e220483. https:\/\/doi.org\/10.1001\/jamapediatrics.2022.0483. (PubMed PMID: 35404395; PubMed Central PMCID: PMC9002717)","journal-title":"JAMA Pediatr."},{"issue":"9656","key":"7221_CR5","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1016\/S0140-6736(08)61929-7","volume":"372","author":"KE Murphy","year":"2008","unstructured":"Murphy KE, Hannah ME, Willan AR, Hewson SA, Ohlsson A, Kelly EN et al (2008) Multiple courses of antenatal corticosteroids for preterm birth (MACS): a randomised controlled trial. Lancet Lond Engl. 372(9656):2143\u201351. https:\/\/doi.org\/10.1016\/S0140-6736(08)61929-7. (PubMed PMID: 19101390)","journal-title":"Lancet Lond Engl."},{"key":"7221_CR6","doi-asserted-by":"publisher","unstructured":"Walters A, McKinlay C, Middleton P, Harding JE, Crowther CA (2022)\u00a0 Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev. 4(4):CD003935. https:\/\/doi.org\/10.1002\/14651858.CD003935.pub5 PubMed PMID: 35377461; PubMed Central PMCID: PMC8978608.","DOI":"10.1002\/14651858.CD003935.pub5"},{"issue":"19","key":"7221_CR7","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1001\/jama.2020.3937","volume":"323","author":"K R\u00e4ikk\u00f6nen","year":"2020","unstructured":"R\u00e4ikk\u00f6nen K, Gissler M, Kajantie E (2020) Associations between maternal antenatal corticosteroid treatment and mental and behavioral disorders in children. JAMA. 323(19):1924\u201333. https:\/\/doi.org\/10.1001\/jama.2020.3937. (PubMed PMID: 32427304; PubMed Central PMCID: PMC7237984.)","journal-title":"JAMA."},{"issue":"2","key":"7221_CR8","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1017\/S0033291718004129","volume":"50","author":"E Wolford","year":"2020","unstructured":"Wolford E, Lahti-Pulkkinen M, Girchenko P, Lipsanen J, Tuovinen S, Lahti J et al (2020) Associations of antenatal glucocorticoid exposure with mental health in children. Psychol Med janv 50(2):247\u2013257. https:\/\/doi.org\/10.1017\/S0033291718004129. (PubMed PMID: 30688183)","journal-title":"Psychol Med janv"},{"issue":"1","key":"7221_CR9","doi-asserted-by":"publisher","first-page":"132.e1","DOI":"10.1016\/j.ajog.2017.11.560PubMedPMID:29138038;PubMedCentralPMCID:PMC5759749","volume":"218","author":"AF Schmidt","year":"2018","unstructured":"Schmidt AF, Kemp MW, Rittenschober-B\u00f6hm J, Kannan PS, Usuda H, Saito M et al (2018) Low-dose betamethasone-acetate for fetal lung maturation in preterm sheep. Am J Obstet Gynecol janv 218(1):132.e1-132.e9. https:\/\/doi.org\/10.1016\/j.ajog.2017.11.560PubMedPMID:29138038;PubMedCentralPMCID:PMC5759749","journal-title":"Am J Obstet Gynecol janv"},{"issue":"2","key":"7221_CR10","doi-asserted-by":"publisher","first-page":"186.e1","DOI":"10.1016\/j.ajog.2009.09.033","volume":"202","author":"M Loehle","year":"2010","unstructured":"Loehle M, Schwab M, Kadner S, Maner KM, Gilbert JS, Brenna JT et al (2010) Dose-response effects of betamethasone on maturation of the fetal sheep lung. Am J Obstet Gynecol. 202(2):186.e1-186.e7. https:\/\/doi.org\/10.1016\/j.ajog.2009.09.033. (PubMed PMID: 20022315)","journal-title":"Am J Obstet Gynecol."},{"issue":"10352","key":"7221_CR11","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S0140-6736(22)01535-5","volume":"400","author":"T Schmitz","year":"2022","unstructured":"Schmitz T, Doret-Dion M, Sentilhes L, Parant O, Claris O, Renesme L et al (2022) Neonatal outcomes for women at risk of preterm delivery given half dose versus full dose of antenatal betamethasone: a randomised, multicentre, double-blind, placebo-controlled, non-inferiority trial. Lancet Lond Engl. 400(10352):592\u2013604. https:\/\/doi.org\/10.1016\/S0140-6736(22)01535-5. (PubMed PMID: 35988568)","journal-title":"Lancet Lond Engl."},{"issue":"24","key":"7221_CR12","doi-asserted-by":"publisher","first-page":"00071","DOI":"10.1016\/j.ajog.2024.02.002","volume":"S0002\u20139378","author":"O Baud","year":"2024","unstructured":"Baud O, Sentilhes L, Ursino M, Doret-Dion M, Alberti C, Aupiais C et al (2024) Survival without severe neonatal morbidity after antenatal betamethasone dose reduction: a post hoc analysis of a randomized non-inferiority trial. Am J Obstet Gynecol. S0002\u20139378(24):00071\u20131. https:\/\/doi.org\/10.1016\/j.ajog.2024.02.002. (PubMed PMID: 38341166)","journal-title":"Am J Obstet Gynecol."},{"issue":"1","key":"7221_CR13","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1097\/AOG.0000000000001179","volume":"127","author":"P Delorme","year":"2016","unstructured":"Delorme P, Goffinet F, Ancel PY, Foix-L\u2019H\u00e9lias L, Langer B, Lebeaux C et al (2016) Cause of preterm birth as a prognostic factor for mortality. Obstet Gynecol. 127(1):40\u20138. https:\/\/doi.org\/10.1097\/AOG.0000000000001179. (PubMed PMID: 26646125)","journal-title":"Obstet Gynecol."},{"issue":"3","key":"7221_CR14","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.semperi.2007.11.003","volume":"32","author":"A Rosenberg","year":"2008","unstructured":"Rosenberg A (2008) The IUGR newborn. Semin Perinatol juin 32(3):219\u2013224. https:\/\/doi.org\/10.1053\/j.semperi.2007.11.003. (PubMed PMID: 18482625)","journal-title":"Semin Perinatol juin"},{"issue":"4","key":"7221_CR15","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1113\/JP276040","volume":"597","author":"A Sehgal","year":"2019","unstructured":"Sehgal A, Gwini SM, Menahem S, Allison BJ, Miller SL, Polglase GR (2019) Preterm growth restriction and bronchopulmonary dysplasia: the vascular hypothesis and related physiology. J Physiol. 597(4):1209\u201320. https:\/\/doi.org\/10.1113\/JP276040","journal-title":"J Physiol."},{"issue":"2","key":"7221_CR16","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2018.7636","volume":"2","author":"RD Cartwright","year":"2019","unstructured":"Cartwright RD, Crowther CA, Anderson PJ, Harding JE, Doyle LW, McKinlay CJD (2019) Association of fetal growth restriction with neurocognitive function after repeated antenatal betamethasone treatment vs placebo: secondary analysis of the ACTORDS randomized clinical trial. JAMA Netw Open. 2(2):e187636. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.7636","journal-title":"JAMA Netw Open."},{"key":"7221_CR17","doi-asserted-by":"publisher","unstructured":"Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al (2019) The diagnosis of bronchopulmonary dysplasia in very preterm infants. An evidence-based approach. Am J Respir Crit Care Med. 200(6):751\u20119. https:\/\/doi.org\/10.1164\/rccm.201812-2348OC PubMed PMID: 30995069; PubMed Central PMCID: PMC6775872.","DOI":"10.1164\/rccm.201812-2348OC"},{"issue":"4","key":"7221_CR18","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1159\/000499361PubMedPMID:30974433;PubMedCentralPMCID:PMC6604659","volume":"115","author":"DG Sweet","year":"2019","unstructured":"Sweet DG, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A et al (2019) European Consensus Guidelines on the management of respiratory distress syndrome - 2019 update. Neonatology 115(4):432\u2013450. https:\/\/doi.org\/10.1159\/000499361PubMedPMID:30974433;PubMedCentralPMCID:PMC6604659","journal-title":"Neonatology"},{"key":"7221_CR19","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2431-13-59","volume":"13","author":"TR Fenton","year":"2013","unstructured":"Fenton TR, Kim JH (2013) A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 13:59. https:\/\/doi.org\/10.1186\/1471-2431-13-59","journal-title":"BMC Pediatr."},{"issue":"6","key":"7221_CR20","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1177\/1933719109332821","volume":"16","author":"JL Morrison","year":"2009","unstructured":"Morrison JL, Orgeig S (2009) Antenatal glucocorticoid treatment of the growth-restricted fetus: benefit or cost? Reprod Sci Thousand Oaks Calif juin 16(6):527\u2013538. https:\/\/doi.org\/10.1177\/1933719109332821. (PubMed PMID: 19276405)","journal-title":"Reprod Sci Thousand Oaks Calif juin"},{"issue":"10","key":"7221_CR21","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1080\/00016340903176784","volume":"88","author":"HL Torrance","year":"2009","unstructured":"Torrance HL, Derks JB, Scherjon SA, Wijnberger LD, Visser GHA (2009) Is antenatal steroid treatment effective in preterm IUGR fetuses? Acta Obstet Gynecol Scand 88(10):1068\u20131073. https:\/\/doi.org\/10.1080\/00016340903176784. (PubMed PMID: 19670049)","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"9","key":"7221_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-065070","volume":"13","author":"K Saito","year":"2023","unstructured":"Saito K, Nishimura E, Ota E, Namba F, Swa T, Ramson J et al (2023) Antenatal corticosteroids in specific groups at risk of preterm birth: a systematic review. BMJ Open. 13(9):e065070. https:\/\/doi.org\/10.1136\/bmjopen-2022-065070","journal-title":"BMJ Open."}],"container-title":["European Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07221-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00431-026-07221-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00431-026-07221-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T03:49:42Z","timestamp":1786420182000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00431-026-07221-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":22,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["7221"],"URL":"https:\/\/doi.org\/10.1007\/s00431-026-07221-w","relation":{},"ISSN":["1432-1076"],"issn-type":[{"value":"1432-1076","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In accordance with the Declaration of Helsinki, ethics approval was granted by the Committee for the Protection of People participating to biomedical research Ile-de-France 1 (n\u00b014242 ND, June, 26th 2016) and the National Agency for Drug Security (n\u00b0160457A-22, May 25th 2016).","order":1,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"568"}}